- Home
- / Lukas Biomedical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lukas Biomedical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$30.3
2024-10-29
Market Capitalization
NT$1.3 B
2024-10-29
Revenue
NT$189.8 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 132.4M | 152.9M | 181.4M | 157.6M | 184.8M | 231.8M | 189.8M |
| Cost of goods sold | 28.8M | 2.5M | 41.8M | 45.6M | 69.0M | 82.3M | 61.6M |
| Gross profit | 104.1M | 150.5M | 139.7M | 113.3M | 116.0M | 150.0M | 128.4M |
| Gross profit margin, % | 78.6% | 98.4% | 77.0% | 71.9% | 62.8% | 64.7% | 67.7% |
| Operating expense total | 80.5M | 107.2M | 97.9M | 113.2M | 128.3M | 161.5M | 191.6M |
| Depreciation and amortization | 31.6M | 50.3M | 48.4M | 43.1M | 36.1M | 31.6M | 28.6M |
| EBITDA | 23.6M | 43.2M | 41.8M | 150.0K | (12.3M) | (11.5M) | (63.1M) |
| EBITDA margin, % | 17.8% | 28.3% | 23.0% | 0.1% | -6.6% | -4.9% | -33.3% |
| EBIT | (9.1M) | (7.2M) | (6.5M) | (44.5M) | (48.2M) | (43.3M) | (91.7M) |
| EBIT margin, % | -6.9% | -4.7% | -3.6% | -28.2% | -26.1% | -18.7% | -48.3% |
| Interest income | 57.0K | 56.0K | 40.0K | 43.0K | 73.0K | 90.0K | 461.0K |
| Interest expense | 2.6M | 5.2M | 4.8M | 4.4M | 2.9M | 3.1M | 3.0M |
| Pre tax profit | (14.3M) | (7.8M) | (10.0M) | (47.8M) | (49.9M) | (47.3M) | (94.5M) |
| Income tax expense | 418.0K | (802.0K) | 586.0K | 1.7M | 151.0K | 78.0K | (95.0K) |
| Net Income | (14.7M) | (7.0M) | (10.5M) | (49.5M) | (50.1M) | (47.4M) | (94.4M) |